ATE192655T1 - Verwendung von histamin-gamma-globulin zur herstellung eines immunomodulierenden und antiinflammatorischen agens - Google Patents
Verwendung von histamin-gamma-globulin zur herstellung eines immunomodulierenden und antiinflammatorischen agensInfo
- Publication number
- ATE192655T1 ATE192655T1 AT94112427T AT94112427T ATE192655T1 AT E192655 T1 ATE192655 T1 AT E192655T1 AT 94112427 T AT94112427 T AT 94112427T AT 94112427 T AT94112427 T AT 94112427T AT E192655 T1 ATE192655 T1 AT E192655T1
- Authority
- AT
- Austria
- Prior art keywords
- agent
- diseases
- histamine
- pharmaceutical composition
- immunomodulating
- Prior art date
Links
- 239000002260 anti-inflammatory agent Substances 0.000 title abstract 3
- 229940121363 anti-inflammatory agent Drugs 0.000 title abstract 3
- 108010074605 gamma-Globulins Proteins 0.000 title abstract 3
- 230000002519 immonomodulatory effect Effects 0.000 title abstract 2
- 239000002955 immunomodulating agent Substances 0.000 title abstract 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 title 2
- 229960001340 histamine Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 4
- 206010014950 Eosinophilia Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010021460 Immunodeficiency syndromes Diseases 0.000 abstract 1
- 208000030852 Parasitic disease Diseases 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 229940125721 immunosuppressive agent Drugs 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21804393A JP3193205B2 (ja) | 1993-08-09 | 1993-08-09 | 好酸球増多抑制剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE192655T1 true ATE192655T1 (de) | 2000-05-15 |
Family
ID=16713756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94112427T ATE192655T1 (de) | 1993-08-09 | 1994-08-09 | Verwendung von histamin-gamma-globulin zur herstellung eines immunomodulierenden und antiinflammatorischen agens |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5780026A (enExample) |
| EP (1) | EP0646376B1 (enExample) |
| JP (1) | JP3193205B2 (enExample) |
| KR (1) | KR100275174B1 (enExample) |
| CN (3) | CN1127983C (enExample) |
| AT (1) | ATE192655T1 (enExample) |
| DE (1) | DE69424362T2 (enExample) |
| ES (1) | ES2146240T3 (enExample) |
| TW (1) | TW258664B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3193205B2 (ja) * | 1993-08-09 | 2001-07-30 | 日本臓器製薬株式会社 | 好酸球増多抑制剤 |
| US6566386B2 (en) | 1993-08-09 | 2003-05-20 | Nippon Zoki Pharmaceutical Co., Ltd. | Immunomodulating and antiinflammatory agent |
| IT1278052B1 (it) * | 1995-03-14 | 1997-11-17 | Mendes Srl | Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per |
| US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6562629B1 (en) | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
| JPH0959180A (ja) * | 1995-08-11 | 1997-03-04 | Nippon Zoki Pharmaceut Co Ltd | 活性化免疫グロブリン |
| US5961969A (en) * | 1996-05-14 | 1999-10-05 | Maxim Pharmaceuticals, Inc. | Stable circulating histamine levels |
| US6071942A (en) | 1996-05-14 | 2000-06-06 | Maxim Pharmaceuticals, Inc. | Elevation of circulating blood histamine levels |
| JPH10212246A (ja) | 1997-01-30 | 1998-08-11 | Nippon Zoki Pharmaceut Co Ltd | 経口投与用製剤 |
| US7232830B2 (en) | 1998-06-26 | 2007-06-19 | Elaine A Delack | Method for treatment of neurodegenerative diseases and effects of aging |
| JP2000143537A (ja) * | 1998-11-13 | 2000-05-23 | Nippon Zoki Pharmaceut Co Ltd | 細胞接着分子発現抑制剤 |
| JP2000143536A (ja) * | 1998-11-13 | 2000-05-23 | Nippon Zoki Pharmaceut Co Ltd | 抗浮腫剤 |
| US6242473B1 (en) * | 1999-01-08 | 2001-06-05 | Maxim Pharmaceuticals, Inc. | Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| DE19944122A1 (de) * | 1999-09-15 | 2001-03-29 | Wolfgang Loh | Histamin-Immunglobulin-Komplexe zur Behandlung von entzündlichen Erkrankungen bei Säugetieren |
| CA2450073C (en) | 2001-07-25 | 2017-08-29 | Biomarin Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| US20090317357A1 (en) * | 2003-02-24 | 2009-12-24 | Lawrence Steinman | Methods for treating or preventing autoimmune disease using histamine h1 receptor-blocking agents |
| EP2671508B1 (en) | 2005-04-28 | 2020-09-16 | Proteus Digital Health, Inc. | Pharma-informatics system |
| JP2010503710A (ja) | 2006-09-18 | 2010-02-04 | ラプトール ファーマシューティカル インコーポレイテッド | 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置 |
| EP2142200B1 (en) | 2007-05-10 | 2012-05-16 | Rajesh Shah | Homeopathy-based formulation |
| ES2919563T3 (es) | 2009-02-20 | 2022-07-27 | Enhanx Biopharm Inc | Sistema de administración de medicamentos a base de glutatión |
| KR20180114970A (ko) | 2009-05-06 | 2018-10-19 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5585526A (en) * | 1978-12-23 | 1980-06-27 | Nippon Zoki Pharmaceut Co Ltd | Remedy for allergic disease |
| US4704273A (en) * | 1982-05-17 | 1987-11-03 | Mcmichael John | Methods and materials for treatment of rheumatoid arthritis |
| US4705685A (en) * | 1982-05-17 | 1987-11-10 | Mcmichael John | Methods and materials for treatment of disease states involving immunological factors |
| US4705687A (en) * | 1985-06-17 | 1987-11-10 | Ortho Pharmaceutical (Canada) Ltd. | Treatment of autoimmune diseases such as rheumatoid arthritis with suppressor factor |
| US5244902A (en) * | 1989-08-21 | 1993-09-14 | Beth Israel Hospital Association | Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| IT1237475B (it) * | 1989-10-06 | 1993-06-07 | Allergeni modificati chimicamente e procedimento per la loro preparazione | |
| US5192773A (en) * | 1990-07-02 | 1993-03-09 | Vertex Pharmaceuticals, Inc. | Immunosuppressive compounds |
| JP3193205B2 (ja) * | 1993-08-09 | 2001-07-30 | 日本臓器製薬株式会社 | 好酸球増多抑制剤 |
-
1993
- 1993-08-09 JP JP21804393A patent/JP3193205B2/ja not_active Expired - Fee Related
-
1994
- 1994-07-30 TW TW083106994A patent/TW258664B/zh active
- 1994-08-05 KR KR1019940019333A patent/KR100275174B1/ko not_active Expired - Fee Related
- 1994-08-08 US US08/287,249 patent/US5780026A/en not_active Expired - Fee Related
- 1994-08-08 CN CN94109522A patent/CN1127983C/zh not_active Expired - Fee Related
- 1994-08-09 ES ES94112427T patent/ES2146240T3/es not_active Expired - Lifetime
- 1994-08-09 AT AT94112427T patent/ATE192655T1/de not_active IP Right Cessation
- 1994-08-09 DE DE69424362T patent/DE69424362T2/de not_active Expired - Fee Related
- 1994-08-09 EP EP94112427A patent/EP0646376B1/en not_active Expired - Lifetime
-
2001
- 2001-08-01 CN CNA011244771A patent/CN1471975A/zh active Pending
- 2001-08-01 CN CNA011244763A patent/CN1471974A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW258664B (enExample) | 1995-10-01 |
| KR950005323A (ko) | 1995-03-20 |
| KR100275174B1 (ko) | 2000-12-15 |
| JPH0753406A (ja) | 1995-02-28 |
| CN1471974A (zh) | 2004-02-04 |
| US5780026A (en) | 1998-07-14 |
| CN1471975A (zh) | 2004-02-04 |
| EP0646376A1 (en) | 1995-04-05 |
| CN1127983C (zh) | 2003-11-19 |
| DE69424362D1 (de) | 2000-06-15 |
| EP0646376B1 (en) | 2000-05-10 |
| JP3193205B2 (ja) | 2001-07-30 |
| CN1121430A (zh) | 1996-05-01 |
| DE69424362T2 (de) | 2000-10-19 |
| ES2146240T3 (es) | 2000-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69424362D1 (de) | Verwendung von Histamin-gamma-globulin zur Herstellung eines immunomodulierenden und antiinflammatorischen Agens | |
| MY131458A (en) | Pyrolopyrimidine compounds | |
| NL300224I1 (nl) | 3-Benzazepinzonen gesubstitueerd met een benzocyclobutyl-of indanylalkyla-minoalkylgroep, bruikbaar voor de behandeling van cardiovasculaire aandoeningen. | |
| FI931370A0 (fi) | Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring | |
| DE59409604D1 (de) | Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12 | |
| ES2157992T3 (es) | Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas. | |
| AU4850290A (en) | Substituted quinolinecarboxylic acids | |
| IL75805A (en) | Pharmaceutical immunosuppressor compositions containing lycorine | |
| EP0553294A4 (en) | Methods and compositions for the treatment of cell proliferation disorders | |
| GR3031149T3 (en) | Process for the manufacture of (s)-3-amino-1-substituted-pyrrolidines. | |
| EP0328634A4 (en) | Pharmaceutical compositions for the treatment of psoriasis | |
| ATE236615T1 (de) | Pharmazeutische zubereitung zur oralen anwendung enthaltend einen histamin-immunoglobulin komplex | |
| GR3015132T3 (en) | Novel ureas and thioureas, preparation thereof and application in therapy. | |
| ITMI931393A0 (it) | Procedimento per il funzionamento di un filtro elettrostatico nonche' filtro elettrostatico per l'attuazione del procedimento | |
| GB2132620B (en) | Novel 6a-methylprednisolone derivatives and their manufacture and use | |
| EP0352652A3 (de) | Verwendung von Imexon als Immunsuppressivum | |
| GR3020597T3 (en) | Phospholipids for the treatment of multiple sclerosis | |
| IT8748439A0 (it) | Metodo per il trattamento di malattie autoimmunitarie basato sull'uso del bendazac | |
| TW279156B (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |